Here's how I'm doing so far. Don't read too much into this: My first purchases were made July 5, the latest were on July 28. So some of these results are from as little as one week worth of 
activity. In separate panels are my own biotech picks, my MFI picks and my Hidden Gems picks, and relevant indexes for comparison. What are the highlights? DECK has been nice to watch. They just announced earnings that were way ahead of guidance, but not that much improved relative to last year. Nevertheless, I guess the street liked what they heard. Everyone seems to be talking about Simple, UGG and the return of Teva sandles. Which is great for DECK.
activity. In separate panels are my own biotech picks, my MFI picks and my Hidden Gems picks, and relevant indexes for comparison. What are the highlights? DECK has been nice to watch. They just announced earnings that were way ahead of guidance, but not that much improved relative to last year. Nevertheless, I guess the street liked what they heard. Everyone seems to be talking about Simple, UGG and the return of Teva sandles. Which is great for DECK.The biotech portfolio is disappointing - the whole industry is down, and the stocks I've picked are especially volatile. But it's been way too short a period to say anything meaningful 
about these stocks. Let the companies have the chance to report on earnings for a few more quarters (CBST) or hopefully some other surprises (MEDX and maybe ALNY in particular). These picks are speculative, based on the probability of the technology paying off. And are definitely buy and hold plays. NBIX spectacularly showed how that could end up - on the downside. More in later posts.
about these stocks. Let the companies have the chance to report on earnings for a few more quarters (CBST) or hopefully some other surprises (MEDX and maybe ALNY in particular). These picks are speculative, based on the probability of the technology paying off. And are definitely buy and hold plays. NBIX spectacularly showed how that could end up - on the downside. More in later posts.
2 comments:
I find it ironic that you have an MFI portfolio and a bio-tech portfolio as Biotech stocks are the exact opposite (or better said at the bottom of the rankings) of MFI top-ranked stocks. If you believe MFI why would you have a portfolio of the bottom decile?
because i'm not picking randomly. it's inspired by the 'one up on wall street' approach - my area is biotech; hopefully this means that i'll have a little better understanding of those markets than stock analysts with no molecular biology training. i don't know whether that's true - hence the three-portfolio-competition.
Post a Comment